首页|通督解郁针法联合补肾止颤方、多巴丝肼片治疗帕金森病伴睡眠障碍患者的效果

通督解郁针法联合补肾止颤方、多巴丝肼片治疗帕金森病伴睡眠障碍患者的效果

扫码查看
目的:观察通督解郁针法联合补肾止颤方、多巴丝肼片治疗帕金森病伴睡眠障碍患者的效果.方法:选取 2021 年 3 月至2023 年 4 月该院收治的 260 例帕金森病伴睡眠障碍患者进行前瞻性研究,按照随机数字表法将其分为研究组与对照组各 130 例.对照组采用补肾止颤方联合多巴丝肼片治疗,研究组在对照组基础上增加通督解郁针法治疗,比较两组睡眠障碍治疗总有效率、匹兹堡睡眠指数(PSQI)评分、帕金森病睡眠量表(PDSS)评分、血清神经递质指标(5-羟色胺、多巴胺、P物质)水平和不良反应发生率.结果:研究组睡眠障碍治疗总有效率为 97.69%,明显高于对照组的 92.31%,差异有统计学意义(P<0.05);治疗后,两组PDSS评分高于治疗前,且研究组高于对照组,两组PSQI评分低于治疗前,且研究组低于对照组,差异均有统计学意义(P<0.05);治疗后,两组 5-羟色胺、多巴胺、P物质等血清神经递质指标水平低于治疗前,且研究组低于对照组,差异均有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:通督解郁针法联合补肾止颤方、多巴丝肼片治疗帕金森病伴睡眠障碍患者可提高睡眠障碍治疗总有效率和PDSS评分,降低PSQI评分和血清神经递质指标水平,效果优于补肾止颤方联合多巴丝肼片治疗.
Effects of Tongdu Jieyu acupuncture combined with Bushen Zhichan prescription and Levodopa and Benserazide hydrochloride tablets in treatment of patients with Parkinson's disease with sleep disorders
Objective:To observe effects of Tongdu Jieyu acupuncture combined with Bushen Zhichan prescription and Levodopa and Benserazide hydrochloride tablets in treatment of patients with Parkinson's disease with sleep disorders.Methods:A prospective study was conducted on 260 patients with Parkinson's disease and sleep disorders admitted to the hospital from March 2021 to April 2023.According to the random number table method,they were divided into study group and control group,130 cases in each group.The control group was treated with Bushen Zhichan prescription combined with Levodopa and Benserazide hydrochloride tablets,while the study group was treated with Tongdu Jieyu acupuncture on the basis of that of the control group.The total effective rate of sleep disorder treatment,the Pittsburgh sleep index(PSQI)score,the Parkinson's disease sleep scale(PDSS)score,the serum neurotransmitter index(5-hydroxytryptamine,dopamine,substance P)levels,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of sleep disorder treatment in the study group was 97.69%,which was significantly higher than 92.31%in the control group,and the difference was statistically significant(P<0.05).After the treatment,the PDSS scores of the two groups were higher than those before the treatment,and that in the study group was higher than that in the control group;the PSQI scores of the two groups were lower than those before the treatment,and that in the study group was lower than that in the control group;and the differences were statistically significant(P<0.05).After the treatment,the levels of serum neurotransmitters such as 5-hydroxytryptamine,dopamine and substance P in the two groups were lower than those before the treatment,those in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Tongdu Jieyu acupuncture combined with Bushen Zhichan prescription and Levodopa and Benserazide hydrochloride tablets in the treatment of the patients with Parkinson's disease and sleep disorders can improve the total effective rate and the PDSS scores,and reduce the PSQI scores and the serum neurotransmitter index levels.Moreover,it is superior to Bushen Zhichan prescription combined with Levodopa and Benserazide hydrochloride tablets treatment.

Parkinson's diseaseSleep disorderTongdu Jieyu acupunctureBushen Zhichan prescriptionLevodopa and Benserazide hydrochloride tablets

赵云、李明月、朱杰

展开 >

河南省直第三人民医院中医科,河南 郑州 450000

帕金森病 睡眠障碍 通督解郁针法 补肾止颤方 多巴丝肼片

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(17)